Eli Lilly and Company collaborates with Mubadala Bio. This partnership advances localized packaging and logistics for Lilly's GLP-1 medicines in Abu Dhabi. The companies announced the agreement at the Abu Dhabi Future Health Summit 2026. This initiative aims to build advanced pharmaceutical capabilities in the region.
The collaboration utilizes a 125,000sqm site in KEZAD, Abu Dhabi. This location features packaging and warehousing facilities. The initiative strengthens Lilly's pharmaceutical contract manufacturing, packaging, and logistics capabilities. Lilly will serve global partners from the UAE. This partnership aligns with Abu Dhabi's goal of becoming a global life sciences hub. It also enhances the region's connections within the global pharmaceutical value chain.